Nymox Pharmaceutical Corp. (NYMX) SEC Filings - Page 1

SEC Filings for Nymox Pharmaceutical Corp. (NYMX) 
$ 8.60 0.00 (0.00%) Volume: 57.13 k 4:00 PM EST Feb 10, 2012
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act5611/14/2011
   
CT ORDER108/26/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act5508/12/2011
   
20-F/AAmendment to a previously filed 20-F8406/03/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act5205/13/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act2004/21/2011
   
20-FAnnual and transition report of foreign private issuers under sections 13 or 15(d)17903/15/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6003/15/2011
   
SC 13G/AAmendment to the SC 13G filing602/15/2011
   
SC 13G/AAmendment to the SC 13G filing602/15/2011
   
SC 13G/AAmendment to the SC 13G filing1302/14/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act212/17/2010
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act3211/12/2010
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act3308/13/2010
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act2705/14/2010
   
<<
First
<
Prev
123456789